SEC Form 4 · accession 0001126234-16-000301

NEWLINK GENETICS CORP · (NLNK)

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 9, 2016

Accepted (ET)

Aug 11, 2016 · 5:17 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001126234

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F1	$10.78	Aug 9, 2016	A	17,774	A	—	Aug 8, 2026	Common Stock	17,774	17,774	D
Stock Option (Right to Buy)^F2	$10.78	Aug 9, 2016	A	4,782	A	—	Aug 8, 2026	Common Stock	4,782	4,782	D

F1Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2010 Non-Employee Directors' Stock Award Plan. One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant.
F2Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan. One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant.